INSIGHTS ON CLINICAL TRIAL PARTNERING

• Why Site Engagement Belongs At Investigators' Meetings

  Investigators’ meetings are a great opportunity to give sites direct access to the teams supporting patient travel and reimbursement, clarify available services early, and surface practical needs before they become study barriers.

• Participant Payments Without Site Burden

  Participant payments can create extra work for clinical trial sites. Learn how clearer ownership, connected workflows, and direct support reduce site burden while preserving visibility.

• Elevating The Site Voice

  A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

• Unlocking Recruitment Potential In Trial-Naïve Sites

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

• One Program. Many Studies: How Experts Keep It All Aligned.

  2/6/2026

  Compare the differences between project and program management in drug development, and how an integrated CRO ensures oversight and continuity from early development through clinical execution.

• Accelerator™ Drug Development 360° CDMO And CRO Solutions

  3/4/2026

  Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.

• Reframing Clinical Vendor Selection

  7/2/2025

  Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.

• Driving Greater Efficiency Through Modular Trial Design

  6/27/2025

  As clinical trials grow more complex and patient-centric, traditional site-based models are proving insufficient and prompting the rise of modular, technology-enabled delivery strategies.

• Why Early Medical Assessment Matters In Clinical Trials

  1/6/2026

  Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.